Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Sanford Burnham Prebys Medical Discovery Institute Dr. Evan Y. Snyder Early Translational I Developmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD) $5,190,752
Stanford University Dr. Jill Helms Early Translational I Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Jackson Labs Pali G. Kaur Early Translational I Mouse Models for Stem Cell Therapeutic Development $3,759,134
Gladstone Institutes, J. David Dr. Warner C Greene Early Translational I Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation $1,280,001
Scripps Research Institute Dr. Martin Friedlander Early Translational I Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration $5,806,321
University of California, Los Angeles Dr. Gabriel H. Travis Early Translational I Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration $5,487,136
Scripps Research Institute Dr. Jeanne F Loring Early Translational I Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation $5,830,771
ViaCyte, Inc. Dr. Olivia G. Kelly Early Translational I Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product $5,405,397
Scripps Health Dr. Darryl D. D’Lima Early Translational I Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis $3,118,431
University of California, Irvine Dr. Frank LaFerla Early Translational I Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease $3,599,997
University of California, Davis Dr Jan A Nolta Early Translational I Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders $2,615,674
University of California, San Diego Dr Yang Xu Early Translational I Developing induced pluripotent stem cells into human therapeutics and disease models $5,165,028
Parkinson’s Institute Mr. James “Bill” William Langston Mr. Early Translational I Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson’s disease research and drug discovery $3,698,646
University of California, Berkeley Ellen Robey Transplantation Immunology Human Immune System Mouse models as preclinical platforms for stem cell derived grafts $1,005,605
Scripps Research Institute Dr. Nicholas R.J. Gascoigne Transplantation Immunology Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance $1,705,554
Stanford University Kenneth Weinberg Transplantation Immunology Engineered immune tolerance by Stem Cell-derived thymic regeneration $1,271,729
University of California, Berkeley Dr. David H Raulet Transplantation Immunology Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue $952,896
Stanford University Dr. Robert Negrin MD Transplantation Immunology Regulatory T cell induced tolerance to ESC transplantation $1,382,658
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 23 24 25 26 27 28 29 30 31 32 33